Guangyuyuan (600771.SH) announced its third quarter report for 2024 on October 25th, with the company's revenue for the first three quarters of the year at 0.894 billion yuan, a decrease of 7.93% year-on-year; net income attributable to shareholders of the listed company was 70.9642 million yuan, a decrease of 22.49% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 65.334 million yuan, a decrease of 18.13% year-on-year; basic earnings per share was 0.14 yuan.
广誉远(600771.SH)：前三季度净利润7096.42万元，同比下降22.49%
Guangyuyuan Chinese Herbal Medicine (600771.SH): The net income for the first three quarters was 70.9642 million yuan, a year-on-year decrease of 22.49%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated